Clear80° FULL FORECASTClear80° FULL FORECAST
Make us your home page
Instagram

Get the quickest, smartest news, analysis and photos from the Bucs game emailed to you shortly after the final whistle.

(View our Privacy Policy)

Indians' Byrd suspended 162 games for PED

CLEVELAND — Marlon Byrd's second strike with performance-enhancing drugs cost him a full season — and, apparently, his career.

The Indians outfielder was suspended 162 games without pay by Major League Baseball on Wednesday after testing positive for Ipamorelin, a growth hormone releasing peptide.

It's Byrd's second violation of MLB's Joint Drug Prevention and Treatment Program. Shortly after he was released in 2012 by Boston, Byrd served a 50-game suspension for testing positive for Tamoxifen, a medication used by body builders.

Byrd, 38, packed his belongings Tuesday night but didn't tell the team about his suspension until he called manager Terry Francona on Wednesday morning. Later, he spoke to his teammates as a group in Cleveland's clubhouse.

"Marlon stood up in front of everybody and took responsibility and apologized," Francona said. "And, basically, he told the guys that his career is over and this is not how he wanted it to end."

In a statement, Byrd, a 15-year veteran, said he accepted responsibility but claimed he did not intentionally ingest a PED.

BREWERS: LH reliever Will Smith, who had been out all season with a sprained ligament in his right knee, was activated from the disabled list.

MARINERS: RHP Felix Hernandez went on the 15-day DL with a strained right calf, sustained while he celebrated one of the team's five home runs Tuesday night.

PIRATES: RF Gregory Polanco was sent to a team doctor to have his left foot examined a day after fouling a ball off the foot.

TIGERS: Manager Brad Ausmus said struggling RHP Anibal Sanchez will be moved to the bullpen.

Indians' Byrd suspended 162 games for PED 06/01/16 [Last modified: Wednesday, June 1, 2016 9:08pm]
Photo reprints | Article reprints

© 2016 Tampa Bay Times

    

Join the discussion: Click to view comments, add yours

Loading...